Cellivate Technologies
Singapore
About Cellivate Technologies
Cellivate Technologies develops engineered cell culture surfaces and coatings that support robust attachment, expansion, and gentle detachment of adherent cells. The portfolio includes treated plates, flasks, and inserts featuring tailored chemistries and micro nanotopographies for stem cell, primary cell, and bioprocess workflows. Services cover application guidance, surface customization for specific cell types, and small-batch to pilot-scale production runs. Solutions integrate with common media and protocols to help researchers improve yields, reproducibility, and downstream viability during scale-up.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Seed (Aug 2024)
- Website: cellivatetech.com
- Phone: +65 8782 6213
Social Profiles
Canonical: https://fsome.com/organization/cellivate-technologies-2851249 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.